Cargando…
A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study
BACKGROUND: Patients with immune-mediated rheumatic diseases (IMRD) are at increased risk of infections, including significant morbidity and high mortality. Considering the potential for unfavorable outcomes of SARS-CoV-2 infection in patients with IMRD, several questions were raised regarding the i...
Autores principales: | Marques, Claudia, Kakehasi, Adriana Maria, Gomides, Ana Paula Monteiro, Paiva, Eduardo Dos Santos, dos Reis Neto, Edgard Torres, Pileggi, Gecilmara Cristina Salviato, Provenza, José Roberto, Mota, Licia, Xavier, Ricardo Machado, Ferreira, Gilda Aparecida, Pinheiro, Marcelo Medeiros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744142/ https://www.ncbi.nlm.nih.gov/pubmed/33156812 http://dx.doi.org/10.2196/24357 |
Ejemplares similares
-
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data
por: Marques, Claudia Diniz Lopes, et al.
Publicado: (2022) -
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
por: Marques, Claudia Diniz Lopes, et al.
Publicado: (2021) -
Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study
por: Gomides, Ana, et al.
Publicado: (2020) -
Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry
Publicado: (2021) -
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
por: dos Reis Neto, Edgard Torres, et al.
Publicado: (2020)